Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
Cipla launches Q-TIB globally, a novel fixed dose combination in a single tablet for TB prophylaxis in HIV.
Read the Cipla's press release here.
To subscribe to the Weekly Newsletter of new posts, enter your email here:
Published: Dec. 6, 2017, 8:04 p.m.
Last updated: Dec. 6, 2017, 9:06 p.m.